Arcus Biosciences Inc. (RCUS)

NYSE: RCUS · Real-Time Price · USD

8.78

0.16 (1.86%)

At close: May 02, 2025, 12:06 PM

Arcus Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-283M	-307M	-267M	52.83M	-122.86M	-84.71M	-49.59M	-53.08M	-17.97M
Depreciation & Amortization	10M	8M	6M	3.84M	4.19M	3.58M	3.66M	2.61M	1.31M
Stock-Based Compensation	76M	73M	65M	55M	22M	8.98M	3.87M	495K	90K
Other Working Capital	-9M	-85M	615M	-367.88M	178.38M	-2.54M	1.4M	24.86M	53K
Other Non-Cash Items	5M	-9M	11M	3.47M	-46K	-1.44M	-177K	-98K	90K
Deferred Income Tax	n/a	n/a	n/a	4.77M	n/a	n/a	-2.1M	416K	-90K
Change in Working Capital	22M	-71M	623M	-375.62M	208.06M	125K	1.33M	24.6M	3.62M
Operating Cash Flow	-170M	-306M	438M	-256.17M	111.17M	-73.46M	-43M	-25.06M	-12.94M
Capital Expenditures	-6M	-24M	-12M	-26.08M	-3.06M	-1.93M	-3.74M	-5.51M	-4.1M
Cash Acquisitions	n/a	n/a	n/a	-22M	431M	-61.14M	n/a	n/a	-1M
Purchase of Investments	-1.04B	-788M	-1.24B	-718.87M	-739.66M	-247.75M	-261.55M	-96.83M	-33.76M
Sales Maturities Of Investments	965M	1.01B	837M	741.08M	308.35M	308.89M	151.85M	53.27M	1M
Other Investing Acitivies	n/a	n/a	3M	22M	-431M	61.14M	-109.7M	-43.56M	-1M
Investing Cash Flow	-84M	194M	-413M	-3.87M	-434.37M	59.21M	-113.44M	-49.07M	-38.86M
Debt Repayment	47M	n/a	n/a	5M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-6K	-54K	-94K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2M	8M	33M	12.34M	4.67M	1.22M	3.96M	519K	283K
Financial Cash Flow	277M	33M	33M	237.34M	438.68M	1.12M	129.07M	107.4M	70.1M
Net Cash Flow	23M	-79M	58M	-22.7M	115.48M	-13.13M	-27.36M	33.27M	18.3M
Free Cash Flow	-176M	-330M	426M	-282.25M	108.11M	-75.39M	-46.74M	-30.57M	-17.04M